Targeting One Key Factor Could Disrupt Brain Tumors in Two Crucial Ways
September 5, 2025, New York — Glioblastoma multiforme (GBM), the most aggressive and common adult brain cancer, remains one of ...
September 5, 2025, New York — Glioblastoma multiforme (GBM), the most aggressive and common adult brain cancer, remains one of ...
In the relentless battle against HER2-positive breast cancer, trastuzumab (commonly known by its brand name, Herceptin) has long stood as ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine